CDT Equity, Inc. (CDT)
0.91
-0.08
(-8.08%)
USD |
NASDAQ |
Oct 05, 16:00
0.99
+0.08
(+8.79%)
After-Hours: 20:00
CDT Equity Total Liabilities (Quarterly) : 23.62M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.62M |
| March 31, 2026 | 21.64M |
| December 31, 2025 | 12.82M |
| September 30, 2025 | 4.274M |
| June 30, 2025 | 4.46M |
| March 31, 2025 | 4.634M |
| December 31, 2024 | 10.99M |
| September 30, 2024 | 12.11M |
| June 30, 2024 | 8.767M |
| March 31, 2024 | 8.016M |
| Date | Value |
|---|---|
| December 31, 2023 | 7.681M |
| September 30, 2023 | 13.10M |
| June 30, 2023 | 6.656M |
| March 31, 2023 | 6.586M |
| December 31, 2022 | 10.09M |
| September 30, 2022 | 4.945M |
| June 30, 2022 | 4.767M |
| March 31, 2022 | 4.707M |
| December 31, 2021 | 0.1925M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Windtree Therapeutics, Inc. | 27.58M |
| Lifecore Biomedical, Inc. | 213.41M |
| Codexis, Inc. | 87.10M |
| Navidea Biopharmaceuticals, Inc. | -- |
| Biostax Corp. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.71M |
| Shareholders Equity (Quarterly) | 103.09M |
| Debt to Equity Ratio | 0.0115 |
| Current Ratio | 0.1258 |
| Net Debt Paydown Yield | 9.55% |